|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
94-95
|
|
pubmed:dateCreated |
2009-12-2
|
|
pubmed:abstractText |
High stone recurrence and biliary restenosis rates in hepatolithiasis patients have been confirmed to be closely related to postoperatively-remnant chronic proliferative cholangitis (CPC), but effective management strategies have not yet been developed. Since CPC is a type of hyperplastic disease, this study was designed to investigate inhibitory effectiveness of cdc2 k ShRNA on hyperplastic behavior and lithogenic potentiality of CPC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0172-6390
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1477-82
|
|
pubmed:dateRevised |
2011-1-11
|
|
pubmed:meshHeading |
pubmed-meshheading:19950813-Animals,
pubmed-meshheading:19950813-CDC2 Protein Kinase,
pubmed-meshheading:19950813-Cholangitis,
pubmed-meshheading:19950813-Chronic Disease,
pubmed-meshheading:19950813-Glucuronidase,
pubmed-meshheading:19950813-Hydroxyproline,
pubmed-meshheading:19950813-Ki-67 Antigen,
pubmed-meshheading:19950813-Lithiasis,
pubmed-meshheading:19950813-Liver Diseases,
pubmed-meshheading:19950813-Male,
pubmed-meshheading:19950813-Mucin 5AC,
pubmed-meshheading:19950813-Proliferating Cell Nuclear Antigen,
pubmed-meshheading:19950813-RNA, Small Interfering,
pubmed-meshheading:19950813-Rats,
pubmed-meshheading:19950813-Rats, Sprague-Dawley
|
|
pubmed:articleTitle |
Practical value of applying cdc2 kinase shRNA to chronic proliferative cholangitis in treatment of hepatolithiasis.
|
|
pubmed:affiliation |
Department of Hepatobiliary Surgery, West China Hospital of Sichuan University, Chengdu, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
